Leg aches on Wegovy: what the clinical evidence tells us

What the trial data and prescribing information actually record

The STEP programme (several large trials of semaglutide 2.4mg) tracked a wide range of adverse events across thousands of participants. The headline findings concern the medicine's gastrointestinal profile: nausea, vomiting, diarrhoea and constipation, which are more frequent and better evidenced than musculoskeletal complaints. Back pain and joint pain do appear in the summary of product characteristics as less common side effects, a category that typically covers events affecting between 1 in 100 and 1 in 10 people. Leg aches specifically are not called out as a distinct, named side effect, which matters when you are trying to work out whether what you are feeling is expected.

The NHS semaglutide medicine guide lists back pain and musculoskeletal pain among the side effects that affect some people. Leg pain falls within that category. It is genuine information (not a reassurance that the symptom does not happen) but it also means leg aches are far less characteristic of semaglutide than the GI effects most patients and prescribers focus on during the first weeks of treatment.

One practical complication: people starting Wegovy are usually doing so alongside meaningful changes to diet and physical activity. Increasing exercise after a long period of lower activity can produce muscle soreness, including in the legs, that has nothing to do with the medicine itself. Separating the two takes a bit of honest reflection about what else has changed.

Indirect routes from Wegovy to leg discomfort

Some of the most plausible explanations for leg aches during Wegovy treatment are not direct pharmacological effects of semaglutide at all. Three mechanisms are worth understanding.

First, GLP-1 medicines slow gastric emptying and reliably reduce appetite. If someone is eating and drinking significantly less than usual (particularly in the early weeks) mild dehydration can follow. Dehydration affects muscle function and can produce cramp-like aching in the legs, particularly at night. Keeping fluid intake consistent matters more than many patients realise once appetite suppression kicks in.

Second, rapid weight reduction changes the load carried by joints and the muscular demands on the legs. Joints and soft tissues that have been under a certain load for years may need time to adapt as that load falls. Early in treatment, before the body adjusts, some people notice aching that resolves over weeks.

Third, the medicine's effect on blood sugar can be relevant for people with type 2 diabetes who are also prescribed semaglutide for that indication. Blood glucose fluctuations can produce neuropathic-style discomfort in the lower limbs. This is a separate clinical matter and worth discussing with your GP if it applies to you.

For a broader look at how body aches on Wegovy present more generally, including what tends to settle on its own and what warrants a call to your prescriber, that page covers the evidence in more detail.

When leg pain should not be waited out

Most leg discomfort that appears during Wegovy treatment is mild, comes and goes, and resolves without intervention. But there are patterns that should be assessed medically rather than attributed to the medicine and ignored.

Sudden, severe calf pain (especially with swelling, warmth or redness) is not a recognised Wegovy side effect pattern. Deep vein thrombosis is not listed as an adverse effect of semaglutide, but it exists as a background risk in the wider population, particularly in people with obesity. A new symptom matching that description warrants the same response it would warrant in any other context: get it checked, promptly.

Similarly, leg pain accompanied by severe stomach pain, especially pain that radiates to the back, should not be attributed to musculoskeletal causes without assessment. The MHRA has highlighted acute pancreatitis as a known, though infrequent, serious effect of GLP-1 medicines; the symptom pattern there centres on abdominal pain, but any unexplained symptom cluster during treatment is worth a clinical conversation rather than a guess.

If your Wegovy is prescribed and managed through a regulated online pharmacy, you should have access to aftercare support for exactly this kind of question. At nume, our prescribers are available for follow-up seven days a week, because starting treatment is only part of what responsible clinical oversight looks like.

The broader picture of muscle and joint effects during GLP-1 treatment

Research into musculoskeletal effects of GLP-1 receptor agonists is ongoing. There is emerging interest in whether significant, rapid loss of body weight produces a degree of lean muscle mass reduction alongside fat loss, a concern that makes adequate protein intake and resistance activity relevant to people on Wegovy, not just for fitness reasons but for maintaining muscle function in the legs and elsewhere.

Current UK guidance recommends a reduced-calorie diet and increased physical activity alongside treatment. That is practical advice that also directly affects whether legs feel strong or achy during treatment. A prescriber or dietitian can help you think through the balance.

Questions about whether Wegovy can cause muscle aches more broadly, or whether Wegovy affects the legs through other mechanisms, are covered separately if you want to go deeper on either angle. If you are specifically trying to understand whether Wegovy can cause body aches across different areas, including the legs, that page looks at the evidence in full. The full side-effects picture for Wegovy puts leg-related symptoms into context alongside the rest of the profile.

If you are considering starting treatment and want to understand how Wegovy works before making any decisions, or if you are already on it and something does not feel right, a clinical conversation is the right move. You can also speak to our prescribers through a free consultation, no commitment, just a proper clinical assessment by a GPhC-registered Independent Prescriber who reviews your case personally, the same day.